'Liquid biopsy' promotes precision medicine by tracking patient's cancer
A team of researchers, including scientists from the Translational Genomics Research Institute (TGen), has reported that analyzing circulating tumor DNA (ctDNA) can track how a patient's cancer evolves and responds to treatment.
Nov 4, 2015
0
22